📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

A phase I study of olaparib in combination with capecitabine-based chemoradiation (CRT) in patients (pts) with locally advanced pancreatic cancer (LAPC). (2020)

First Author: Evans T

Attributed to: Glasgow Molecular Pathology (GMP) Node funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.2020.38.4_suppl.709

Publication URI: http://dx.doi.org/10.1200/jco.2020.38.4_suppl.709

Type: Journal Article/Review

Parent Publication: Journal of Clinical Oncology

Issue: 4_suppl